Portfolio company
Teitur Trophics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops neuroprotective peptide therapies for patients suffering from neurodegenerative diseases, including Parkinson's disease, Huntington's disease, and frontotemporal dementia.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
PharmatrophiX
The company develops small-molecule therapies targeting neurotrophin receptors for patients with Alzheimer's disease and other neurodegenerative disorders.
Scripta Therapeutics
The company develops therapeutics that modulate transcription factor activity to treat neurodegenerative diseases for patients with conditions such as Alzheimer's and Parkinson's.
NeurOdys Therapeutics
This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.
Muna Therapeutics
This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.
Therapeutics Neurodegenerative diseases
This company develops diagnostic tools and therapeutics for patients with neurodegenerative diseases including Alzheimer's and progressive supranuclear palsy.
Yumanity Therapeutics
This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.
CuraSen Therapeutics
This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.
AZ Therapies
This biopharmaceutical company develops therapies for neurodegenerative diseases, including Alzheimer's disease and ischaemic stroke, to treat patients and improve their cognitive health.
